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Background: Patients with lumbar spinal stenosis (LSS) are at a great risk of a fall and fracture, 
which vitamin D protects against. Vitamin D deficiency is expected to be highly prevalent in LSS 
patient, and pain is thought to have a profound effect on vitamin D status by limiting activity and 
sunlight exposure. 
Objective: To identify the prevalence of vitamin D deficiency (serum 25-hydroxyvitamin D [25-OHD] 
< 20ng/mL) and its relationship with pain. 
Study Design: Nonblinded, cross-sectional clinical study.
Setting: University-based outpatient clinic of the Department of Orthopedic Surgery, Yonsei 
University College of Medicine, Korea.
Methods: Consecutive patients who visited the orthopedic outpatient clinic for chronic low back pain 
and leg pain and were diagnosed as LSS between May 2012 and October 2012 were included. Pain 
was categorized into 4 groups based on location and severity: 1) mild to moderate back or leg pain; 2) 
severe back pain; 3) severe leg pain; and 4) severe back and leg pain. Covariates for vitamin D deficiency 
included age, sex, body mass index, level of education, medical history, season, region of residence, 
sunlight exposure score and functional disability. 25-OHD level was measured by radioimmunoassay, 
and bone metabolic status including bone mineral density and bone turnover markers was also 
measured. Multivariable logistic regression modeling was used to adjust all risk estimates for covariates. 
Results: The study had 350 patients enrolled. Mean serum 25-OHD level was 15.9 ± 7.1 ng/mL 
(range, 2.5 ~ 36.6). of the 350 patients, 260 patients out of 350 (74.3%) were vitamin D deficient. 
Univariate logistic regression analysis showed a significantly higher prevalence of vitamin D deficiency 
in the following patients: 1) medical comorbidity; 2) urban residence rather than rural; 3) lower score 
for sunlight exposure; and 4) severe leg pain, or severe back and leg pain rather than mild to moderate 
pain. Pain category was significantly associated with lower sunlight exposure; however, the association 
between pain category and vitamin D deficiency remained significant even after adjustment for the 
sunlight exposure. Furthermore, severe back pain, and severe back and leg pain were also associated 
with higher incidence of osteoporosis and higher level of bone resorption marker (serum CTx). 
Limitations: The limitation of our study is that due to its cross-sectional design, causal relationships 
between pain and vitamin D deficiency could not be established.
Conclusion: Vitamin D deficiency was highly prevalent in LSS patients (74.3%), and severe pain 
was associated with higher prevalence of vitamin D deficiency and osteoporosis which could be 
potential risk factors or a fall and fracture. As evidenced by the present study, assessment of serum 
25-OHD and bone mineral density are recommended in LSS patients with severe pain, and active 
treatment combining vitamin D, calcium, or bisphosphonate should be considered according to the 
status of the bone metabolism.
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the strong relationship between disease severity and 
vitamin D deficiency in Parkinson disease (23). A recent 
study also demonstrated that vitamin D was signifi-
cantly correlated with functional improvement at one 
year postoperatively in the patients with LSS (16).
Knowledge about vitamin D levels in LSS patients 
might provide important clinical information, since it 
draws attention to the poor vitamin D levels in LSS pa-
tients and provides possible strategies to improve those 
levels. Therefore, the objectives of present study were 
to determine the prevalence of vitamin D deficiency in 
LSS patients and its determinants including the degree 
of pain.
Methods
Study Subject
A single-center cross-sectional study was per-
formed. The study was designed according to STROBE 
(Strengthening the Reporting of Observational studies 
in Epidemiology) guidelines. Consecutive patients who 
visited the orthopedic outpatient clinic for chronic low 
back pain and leg pain and were diagnosed as LSS 
between May 2012 and October 2012 were included. 
The diagnosis of LSS was previously established with 
radiculopathy and neurogenic claudication with low 
back pain confirmed by neural canal stenosis at the 
relevant level based on magnetic resonance imaging 
(MRI). Stenotic lesion was defined as a midsagittal di-
ameter of less than 12 mm on MRI (24). Patients were 
excluded if they met any of the following criteria: 
1. Premenopausal women; 
2. Identifiable motor weakness on both lower 
extremities; 
3.  Neurodegenerative disorders that can have an ef-
fect on walking; 
4. History of fracture within one year; 
5. Evidence of metabolic bone disease (hypo- or hy-
perparathyroidism and chronic renal disease, in 
particular); 
6. Known rheumatoid arthritis or symptomatic os-
teoarthritis of the hip, knee, and ankle (Kellgren 
Lawrence grade III or more on x-ray); 
7. Any history or sign of medical comorbidity affecting 
vitamin D metabolism (gastric surgery, chronic liver 
disease, renal failure, intestinal malabsorption, sys-
temic infection, and neoplasm in particular); 
8.  Use of medications that can influence bone me-
tabolism (anti-osteoporotic drug, corticosteroid, 
Vitamin D performs an important physiological role in maintaining extracellular calcium ion levels, which is the prerequisite for the 
diverse signaling pathways related to musculoskeletal 
function (1,2). Vitamin D supplementation has not 
only a protective effect on fractures by its critical role 
in bone mineralization (3), but also on falls through 
improved muscle function (4-6). Moreover, vitamin D 
receptors are expressed in many other tissues beyond 
the musculoskeletal system, and it also plays protective 
physiologic roles against several chronic diseases such 
as cancer, osteoarthritis, diabetes, and cardiovascular 
conditions (7-10). Furthermore a meta-analysis showed 
vitamin D supplementation reduced all causes of 
mortality (11), and it is different from vitamin E, A, 
or beta-carotene which showed an increase in the 
mortality rate (12). 
Lumbar spinal stenosis (LSS) is a common degen-
erative disease in the elderly, caused by impingement 
of the spinal canal by degenerative spurs and hypertro-
phy of ligaments. Patients with symptomatic LSS have 
an impaired walking ability (13), high turnover bone 
metabolism (14), and co-morbidities such as diabetes 
and hypertension (15), which, in part, are thought to 
be related to vitamin D deficiency. As a result, vitamin 
D deficiency is expected to be highly prevalent in LSS 
patients (16). This is clinically important because a vita-
min D deficiency can have a deleterious impact on falls 
by aggravating a functional disturbance of the lower 
extremity eventually causing a fracture. However, there 
has been no study regarding the etiology of vitamin D 
deficiency in LSS patients. 
Vitamin D is acquired mainly through the sunlight 
exposure (80 – 90%) and additionally through nutri-
tional intake (10 – 20%) (17). Based on this, there have 
been numerous studies demonstrating the potential 
determinants of vitamin D deficiency in the general 
population (18). Age, seasons, living areas, and occupa-
tions were identified as risk factors (19). However, such 
risk factors seem to have only a small role as the deter-
minant of the vitamin D level in patients with specific 
diseases that are directly associated with vitamin D me-
tabolism, such as chronic renal failure, Crohn’s disease, 
and chronic liver disease. Instead, vitamin D status was 
more influenced by the severity of the disease (20-22). 
It can be hypothesized that the degree of pain experi-
enced by LSS patients is closely related to their vitamin 
D status; in other words, severe pain might hinder daily 
activities and consequently sunlight exposure. This as-
sumption is in line with previous reports demonstrating 
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hormone replacement, anticonvulsant, and prod-
ucts containing vitamin D, in particular); and 
9. History of psychiatric disorder including depression. 
The following assessments were conducted by a 
trained clinical research coordinator, who followed 
detailed testing protocols. The institutional review 
board of our institute approved the study protocol (No. 
4-2012-0207), and informed consent was obtained from 
the patients. 
Assessment of Pain 
The assessment of pain in older adults is complex 
because they present with pain of varying severity, dura-
tion, and location (25). This is also true with LSS patients 
who present with chronic pain of varying severity in the 
wide region from the back to the lower extremities. For 
this study, assessment was done for pain occurring quite 
often or almost every day during the past month. Pain 
was then categorized by location and severity according 
to the previous study (26,27).
Pain location was recorded using a validated McGill 
Pain Map (28,29) showing the front and back of a hu-
man figure, and divided as back pain and/or leg pain. 
Pain severity was measured as the average pain in the 
past month based on a numeric rating scale (NRS), 
which has been validated for use in older populations 
with varying cognitive status, ranging from 0 to 10 (with 
10 representing the worst pain) (30). Pain severity was 
described with location-specific ratings (for back and/
or leg), and divided into categorized subgroups: mild, 
moderate, and severe. According to the previous study, 
an NRS score of 1 to 4 was used for mild pain, 5 – 6 for 
moderate, and 7 – 10 for severe pain (31-33). Ultimately 
pain was categorized into 4 groups based on location 
and severity: 
1. Mild to moderate back or leg pain (also expressed 
as mild to moderate pain), 
2. Severe back pain and mild to moderate leg pain 
(also expressed as severe back pain), 
3. Severe leg pain and mild to moderate to back pain 
(also expressed as severe leg pain), and 
4. Back and leg pain, severe in both sites (also ex-
pressed as severe back and leg pain). 
Measurement of 25-Hydroxyvitamin D (25-
OHD)
After an overnight fasting, a blood sample was 
taken between 8:30 and 9:30 AM to correct for circa-
dian variation. Then, serum 25-OHD was measured in 
all 350 patients by radioimmunoassay (Diasorin, Inc., 
Stillwater, Minnesota, USA). The intra-assay coefficient 
of variation (CV) was less than 12.5% and the inter-
assay CV was less than 11.0% (34) . According to the 
level of 25-OHD, vitamin D deficiency was defined as a 
25-OHD level of less than 20 ng/ml (50 nmol/L), vitamin 
D insufficiency as 21 to 29 ng/ml, and a normal level as 
above 30 ng/ml (75 nmol/L) (35-38).
Assessment of Bone Metabolism
The following assessments were done to under-
stand the bone metabolic status of LSS patients. Bone 
mineral density (BMD) of the total lumbar, total hip, 
and femoral neck was measured by dual-energy x-ray 
absorptiometry (QDR-4500A, Hologic, Waltham, MA, 
USA). Patients with a T score below -2.5 in at least one 
of the 3 sites were diagnosed with osteoporosis. Af-
ter an overnight fasting, the following blood samples 
were taken between 8:30 and 9:30 AM to correct for 
circadian variation. Serum measurements included 
alkaline phosphatase (ALP) and osteocalcin as bone 
formation markers, and C-terminal telopeptide of 
type I collagen (CTx) as a bone resorption marker. ALP 
was measured using an enzymatic method (Hitachi 
7600, Hitachi Co., Tokyo, Japan), and the coefficient 
variation (CV) was 2.88%. Osteocalcin and CTx were 
measured by electrochemiluminescence immunoassay 
using an automated instrument (Cobas 6000, Roche 
Diagnostics, Mannheim, Germany). The CV values for 
CTx were 2.97% and 1.51% at plasma levels of 0.32 and 
2.77 mg/L, respectively. The CV values for osteocalcin 
were 0.97% and 1.06% at plasma levels of 25.3 and 
84.1 mg/L, respectively. 
Covariates 
Sociodemographic data
Sociodemographic characteristics assessed in the 
interview included age, sex, and years of education. 
Height and weight for body mass index (BMI) were 
measured, and categorized as < 23, 23 to < 25, and ≥ 25 
kg/m2, which are the cut-off points for normal (includ-
ing underweight), overweight, and obesity for Asian 
populations. 
Medical history 
A medical history was obtained from every patient 
with use of a standardized questionnaire.
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Region of Residence and Functional Disability by 
Oswestry Disability Index Scores
The region of residence was asked and dichoto-
mized as urban and rural according to the previous 
study (19). Functional disability was measured by the 
validated Korean version of the Oswestry disability in-
dex (ODI) (version 2.0) (39) with scores ranging from 0 
to 100), which is widely used for patients with LSS.
Season and Sunlight Exposure
Dates for the measurement of serum 25-OHD were 
recorded and categorized as spring (March to May), 
summer (June to August), fall (September to Novem-
ber), and winter (February and December). Sunlight ex-
posure was based on a previous study (40) as a 5-point 
scale; a score of one was assigned to patients who 
avoided sunlight exposure and a score of 5 to patients 
who were exposed to sunlight on average for more 
than 30 minutes per day. 
Statistical Analysis
Independent variables including pain and covari-
ates were categorized as shown (Table 1). To explore 
the graded association with other variables, functional 
disability and bone markers were divided into 3 catego-
ries based on the 33th and 66th percentiles. Univariate 
logistic regression analysis was performed to identify 
odds ratios and their P-values for each independent 
variable for vitamin D deficiency (Table 1). To find the 
association between pain and the other covariates, 
data were presented according to the pain (Table 2), 
then, Chi-square analysis for categorical variables and 
analysis of the variance test for quantitative variables 
were done. Multivariate logistic regression models 
were used to investigate the association between pain 
category and vitamin D deficiency (Table 2). The pain 
category of mild to moderate pain served as a reference 
group. Variables significantly associated with vitamin 
D deficiency in the univariate analysis (P < 0.10) were 
then entered in a multivariate analysis using a logistic 
regression model. To identify the association between 
pain category and bone metabolism (osteoporosis, CTx, 
osteocalcin, and ALP), multivariate binary or ordinal 
logistic regression analysis was carried out with ad-
justment for age, sex, and BMI. All statistical analyses 
were performed using the SPSS 17.0.0 statistics package 
(SPSS, Inc., Chicago, IL). A value of P < 0.05 was accepted 
as significant.
Results
Patients Characteristics and Prevalence of 
Vitamin D Deficiency
A total of 350 patients were included in the study. 
Mean age of the study population was 66.1 years 
(range, 50 to 79). Included were 268 (76.6%) women 
and 82 (23.4%) men. All patients in this study were of 
the same ethnicity. Mean serum 25-OHD level was 15.9 
± 7.1 ng/ml (range, 2.5 ~ 36.6). Of the included patients, 
74.3% (260 of 350) were vitamin D deficient, 22.9% (80 
of 350) were vitamin D insufficient, and only 2.9% (10 
of 350) were normal (Table 3).
Variables Associated with Vitamin D 
Deficiency 
Univariate logistic regression analysis showed an 
increased prevalence of vitamin D deficiency according 
to medical history, region of residence, sunlight expo-
sure score, and pain (Table 1). In detail, the prevalence 
of vitamin D deficiency was significantly higher in pa-
tients with 
1. Medical comorbidity; 
2. Urban residence; 
3. Lower score for sunlight exposure; and 
4. Severe leg pain or severe back and leg pain (P < 
0.05). 
The prevalence of vitamin D deficiency was not 
affected by age, sex, BMI, level of education, season 
when the blood sample was drawn, and functional dis-
ability (ODI score). 
Relationship Between Pain and Other 
Variables Including Bone Metabolism
Pain was significantly associated with sunlight ex-
posure scores (P = 0.010). The other covariates, includ-
ing functional disability (P = 0.169), were not associated 
with pain (Table 2). Severe back pain and severe back 
and leg pain were also associated with a higher inci-
dence of osteoporosis and higher level of bone resorp-
tion marker (serum CTx) after adjustment for age, sex, 
and BMI (Fig. 1a, 1b).
Prevalence of Vitamin D Deficiency According 
to Pain Category
After multivariate adjustment, the more severe 
pain category continued to be independently associat-
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ed with an increased prevalence of vitamin D deficiency 
(Fig. 2). After adjustment for medical history, region of 
residence, and sunlight exposure score, the association 
between pain and vitamin D deficiency remained sig-
nificant, although severe back pain did not show a sig-
nificantly increased odds ratio for vitamin D deficiency 
compared with mild to moderate pain (P = 0.068).
Table 1. Variables associated with vitamin D deficiency. 
Variables Category
No. of  all 
patients
No. with 
vitamin D 
deficiency
Prevalence 
of  vitamin D 
deficiency
Odds ratio P value
Age (years)
50–59 72 56 77.8% 1.472 (0.764, 2.836)
0.473 60–69 152 107 70.4% reference
70–79 126 94 74.6% 1.235 (0.726, 2.101)
Sex
Women 268 198 73.9% 1.103 (0.634, 1.918)
0.729 
Men 82 59 72.0% reference
Body mass index 
(kg/m2)
<23 114 90 78.9% 1.820 (0.986, 3.359)
0.160 23 to <25 101 68 67.3% reference
≥25 135 99 73.3% 1.335 (0.759, 2.346)
Level of education
<High school 238 180 75.6% 1.693 (0.789, 3.631)
0.327 High school graduate 78 55 70.5% 1.304 (0.555, 3.068)
>High school 34 22 64.7% reference
Medical history
No 109 68 62.4% 2.191 (1.337, 3.593)
0.002 
Yes 241 189 78.4%
Season 
Spring 96 77 80.2% 1.902 (0.940, 3.851)
0.273 
Summer 93 65 69.9% 1.090 (0.561, 2.118)
Autumn 72 49 68.1% reference
Winter 89 66 74.2% 1.347 (0.678, 2.675)
Region
Urban 244 190 77.9% 2.048 (1.246, 3.367)
0.005 
Rural 106 67 63.2% reference
Sunlight exposure 1–5 points 0.725 (0.596, 0.881) 0.001 
Pain 
mild to moderate pain 101 56 55.4% reference
< 0.001
severe back pain 61 45 73.8% 2.260 (1.131, 4.517)
severe leg pain 89 72 80.9% 3.403 (1.762, 6.573)
severe back and leg pain 99 84 84.8% 4.500 (2.291, 8.839)
Functional disability 
(ODI scores)
first tertile (17.8–44.0) 113 79 69.9% reference
0.362 second tertile (44.4–58.0) 111 80 72.1% 1.134 (0.643, 1.999)
third tertile (60.0–98.0) 126 98 77.8% 1.477 (0.820. 2.663)
discussion
There have been consistent reports on the associa-
tion between low vitamin D level and poor functional 
performance (41,42). Vitamin D supplementation in-
creased muscle strength and balance (6,43), and a 
meta-analysis of 5 randomized clinical trials (with a 
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Table 2. Relationship between pain and other covariate
Variables Category
mild to 
moderate pain
severe back pain severe leg pain
severe back 
and leg pain
P value
No. of patients 101 61 89 99
Age (years)
50–59 24 (23.8%) 11 (18.0%) 19 (21.3%) 18 (18.2%)
0.840 60–69 46 (45.5%) 28 (45.9%) 35 (39.3%) 43 (43.4%)
70–79 31 (30.7%) 22 (36.1%) 35 (39.3%) 38 (38.4%)
Sex
Women 75 (74.3%) 47 (77.0%) 68 (76.4%) 78 (78.8%)
0.901 
Men 26 (25.7%) 14 (23.0%) 21 (23.6%) 21 (21.2%)
Body mass index 
(kg/m2)
< 23 30 (29.7%) 25 (41.0%) 25 (28.1%) 34 (34.3%)
0.289 23 to < 25 36 (35.6%) 17 (27.9%) 22 (24.7%) 28 (28.3%)
≥ 25 35 (34.7%) 19 (31.1%) 42 (47.2%) 37 (37.4%)
Level of education
<High school 65 (64.4%) 41 (67.2%) 67 (75.3%) 65 (65.7%)
0.601 High school graduate 24 (23.8%) 16 (26.2%) 14 (15.7%) 24 (24.2%)
> High school 12 (11.9%) 4 (6.6%) 8 (9.0%) 10 (10.1%)
Medical history
No 37 (36.6%) 18 (29.5%) 31 (34.8%) 23 (23.2%)
0.176 
Yes 64 (63.4%) 43 (70.5%) 58 (65.2%) 76 (76.8%)
Season 
Spring 23 (22.8%) 19 (31.1%) 25 (28.1%) 29 (29.3%)
0.137Summer 21 (20.8%) 20 (32.8%0 25 (28.1%) 27 (27.3%)
Autumn 31 (30.7%) 5 (8.2%) 18 (20.2%) 18 (18.2%)
Winter 26 (25.7%) 17 (27.9%) 21 (23.6%) 25 (25.3%)
Region
Urban 70 (69.3%) 44 (72.1%) 56 (62.9%) 74 (74.7%)
0.346 
Rural 31 (30.7%) 17 (27.9%) 33 (37.1%) 25 (25.3%)
Sunlight exposure 1–5 points 3.5 ± 1.3 2.9 ± 1.4 3.2 ± 1.2 3.0 ± 1.2 0.010 
Functional 
disability 
(ODI scores)
first tertile (17.8–44.0) 42 (41.6%) 21 (34.4%) 23 (25.8%) 31 (31.3%)
0.169 second tertile (44.4–58.0) 36 (35.6%) 18 (29.5%) 32 (36.0%) 31 (31.3%)
third tertile (60.0–98.0) 23 (22.8%) 22 (36.1%) 34 (38.2%) 37 (37.4%)
Table 3. Patients characteristics and prevalence of  vitamin D deficiency
Category
No. of  
patients
25–OHD level
No. of  patients with 
vitamin D deficiency (%)
No. of  patients with vitamin 
D insufficiency (%)
No. of  patients with 
normal vitamin D
All patients 350 15.9 (7.1) 260 (74.3%) 80 (22.9%) 10 (2.9%)
Age
50–59 72 16.0 (7.1) 57 (79.2%) 11 (15.3%) 4 (5.5%)
60–69 152 15.9 (6.7) 109 (71.7%) 41 (27.0%) 2 (1.3%)
70–79 126 15.8 (7.6) 94 (74.6%) 28 (22.2%) 4 (3.2%)
Sex
Women 268 16.0 (6.6) 200 (74.6%) 60 (22.4%) 8 (3.0%)
Men 82 15.9 (7.2) 60 (73.2%) 20 (24.4%) 2 (2.4%)
BMI
< 23 114 15.5 (7.0) 90 (79.0%) 21 (18.4%) 3 (2.6%)
23 to < 25 101 17.2 (6.9) 71 (70.3%) 26 (25.7%) 4 (4.0%)
≥ 25 135 15.3 (7.2) 99 (73.3%) 33 (24.4%) 3 (2.2%)
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Fig. 1. Relationship between pain category and bone metabolism. a) result of  multivariate binary logistic regression analysis, adjusted 
for age, gender, and BMI. b), c), and d) result of  multivariate ordinal logistic regression analysis, adjusted for age, gender, and BMI.
A
B
C
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total of 1,237 subjects) revealed that increased vitamin 
D intake reduced the risk of a fall by 22% among older 
individuals with stable health (44). Although the exact 
mechanisms of such protective effects are not well un-
derstood, increased protein synthesis in muscle through 
vitamin D receptor activation or myopathy of vitamin D 
deficiency are suggested (4,45). Vitamin D deficiency in 
LSS patients might render additional hazardous effects 
on lower extremity function, since patients already have 
impaired lower extremity function and increased risk 
of a fall by neurologic claudication and radiculopathy. 
Hence it is safe to say that patients with LSS might be 
in a vicious cycle of walking impairment and vitamin D 
deficiency, and vice versa.  
As expected, our study showed a high prevalence 
of vitamin D deficiency (74.3%) in 350 LSS patients. A 
normal range of 25-OHD was noted in only 2.9% (10 
of 350) of patients. The mean serum 25-OHD level was 
15.9 ± 7.1 ng/mL (range 2.5 ~ 36.6) (Table 3). This is a 
significantly lower value than the domestic norm data 
such as the fourth Korea National Health and Nutrition 
Examination Surveys (KNHANES IV), which was the larg-
est nationwide epidemiologic study of vitamin D status 
in Korea and assessed serum 25-OHD by the same ana-
lytical technique. According to the result of KNHANES 
IV, serum 25-OHD levels (mean ± standard deviation) 
were as follows: 22.9 ± 7.6 and 19.9 ± 7.5 each for 50- 
to 59-year old men and women; 23.8 ± 7.5 and 20.0 ± 
7.9 each for 60- to 69-year old men and women; and 
23.0 ± 8.3 and 19.0 ± 8.0 each for 70- to 79-year old 
men and women (19). Such low vitamin D status has 
another important meaning in that it is associated with 
low bone mineral density (46). In this case, the Interna-
tional Osteoporosis Foundation (47) and the Endocrine 
Society (48) suggested a threshold of 30 ng/mL for the 
reduction of falls and fractures, which LSS patients are 
expected to have a higher chance of, and there is a 
greater gap compared with our results. 
The combination of pain and poor vitamin D lev-
els of LSS patients was highlighted for the first time 
by the findings from the current analysis. Vitamin D 
deficiency was more common among patients with 
severe pain (severe leg pain and severe back and leg 
pain) compared to patients with mild to moderate 
pain. Furthermore, the 2 pain subgroups were associ-
ated with a higher incidence of osteoporosis (Fig. 1a) 
and higher bone resorption marker (CTx). Univariate 
logistic regression included medical history, region of 
residence, and sunlight exposure scores as other sig-
nificant variables for vitamin D deficiency; however, 
demographic data including age, gender, and BMI were 
not associated with vitamin D deficiency in LSS patients. 
There was also no association between disability by ODI 
scores and vitamin D deficiency. Pain location, severity, 
and disability are closely related as key dimensions for 
pain assessment recommended by the American Geri-
atrics Society (49), and the ODI score is a widely used 
and validated measurement tool for disability in LSS 
patients (39). However, ODI scores seem not to reflect 
outdoor activity related to sunlight exposure in LSS 
patients (16,50). 
Because serum 25-OHD concentration is strongly 
associated with sunlight exposure (17), the relationship 
between disease severity and serum 25-OHD level is 
Fig. 2. Prevalence of  vitamin D deficiency according to pain category.
www.painphysicianjournal.com  173
Relationship Between Pain and vitamin D in Lumbar Spinal Stenosis
also present in several diseases associated with patients’ 
mobility, such as Parkinson disease (23) and peripheral 
arterial disease (51). In this sense, the first hypothesis 
for the relationship between pain and vitamin D in 
LSS patients (Fig. 3) is that pain, typically presented by 
neurologic claudication and lower leg radiculopathy in 
LSS patients, is also directly associated with patients’ 
mobility, and can cause hypovitaminosis D by limiting 
sunlight exposure. However, in this study LSS patients 
demonstrated a strong association between pain and 
vitamin D deficiency even after adjustment for sunlight 
exposure, implying pain itself has a more profound ef-
fect on vitamin D status than sunlight exposure. More-
over, sunlight exposure scores failed to show significant 
differences within 3 severe pain categories (severe leg 
pain, severe back pain, and severe back and leg pain) 
despite their evident differences from the odds ratios 
for vitamin D deficiency. 
The second hypothesis is an immobilization-
induced hypercalemia. Hypercalcemia is closely related 
with immobilization (52,53) and can decrease 1,25-hy-
droxyvitamin D by inhibiting 1-α hydroxylase or inhibit-
ing PTH secretion. This tendency was demonstrated in 
patients with Parkinson disease (23), and 25-OHD level 
was also significantly decreased in patients with a more 
advanced stage. To confirm this relationship, more pre-
cise evaluation of the bone metabolic status including 
serum PTH, 1,25-hydroxyvitamin D, and serum calcium 
is needed. 
The next hypothesis is about hypovitaminosis 
D induced pain. There is evidence for an association 
between low vitamin D status and pain in the general 
population (54-57). The pain included chronic back 
pain, diffuse musculoskeletal pain or chronic wide-
spread pain, and polymyalgia; and vitamin D was sug-
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Fig. 3. Diagram for the relationship between pain and hypovitaminosis D.
gested as the cause of such nonspecific pain. Although 
low back and leg pain has definitive causes in LSS 
patients, the contribution of vitamin D on pain cannot 
be completely ignored. Therefore, it can be said that 
an already lower vitamin D level in patients with LSS 
results in increased pain perception from neurologic 
claudication.
The final hypothesis is that pain might be also as-
sociated with vitamin D intake. A cross-sectional study 
showed a strong association between chronic nonma-
lignant pain and decreased appetite, and appetite im-
pairment was significantly associated with higher pain 
intensity scores, even adjusted for potential confound-
ers including pain medication (58). Therefore, vitamin 
D intake is also expected to be low in LSS patients with 
severe pain. Moreover, the association between serum 
25-OHD and vitamin D intake may be stronger when 
the influence of solar radiation is weaker, especially in 
areas of the world with limited UVB exposure including 
Korea (59-61). 
liMitations
The main limitation of our study is that due to its 
cross-sectional design, causal relationships between 
pain and vitamin D deficiency could not be estab-
lished. Second, sun exposure was measured indirectly 
by asking the duration of sunlight exposure. For es-
timates of self-reported individual sunlight exposure, 
no validated sunlight questionnaires are widely used. 
Moreover, regardless of the details in the question-
naire, measurement of sunlight exposure through 
questionnaire shows a low correlation with serum 25-
OHD (62). Direct, validated, and reliable tools to quan-
tify serum 25-OHD from sunlight might have provided 
more convincing evidence. Third, an investigation of 
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vitamin D intake was not performed. However, the 
known inaccuracy is always present in assessing vita-
min D from existing nutrient databases (59). Moreover, 
there are no domestic instruments that can investigate 
the vitamin D intake and also no data that can be used 
to find the contents contained in Korean foods (60). 
Therefore, it was impossible to assess vitamin D intake 
in our study. Fourth, we did not investigate the gen-
eral activity level, which can also influence vitamin D 
deficiency. However, in LSS patients, physical activity is 
expected to be closely related to disability (63) which 
was investigated as ODI scores in our study, and we 
judged that adding such a variable may weaken the 
power of regression analysis. 
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